Skip to main content

FDA recall, , Moderate risk

Philips Allura Xper FD Interventional Fluoroscopic X-Ray Systems

Allura Xper FD has a firmware issue that could lead to loss of geometry movements.

What happened

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. began a recall of Allura Xper FD interventional fluoroscopic x-ray systems on June 29, 2026, due to a firmware issue potentially leading to loss of geometry movements. The recall involves 4,252 units distributed worldwide, including the US Nationwide and many other countries. The FDA added the recall to its Enforcement Report and classified it on August 10, 2026, with it in the weekly report on August 19, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its model number and UDI-DI are listed under that product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Allura Xper FD

    Model number
    • 722026
    • 722027
    • 722028
    • 722029
    • 722035
    • 722038
    • 722039
    • 722058
    UDI-DI
    • 00884838054202
    • 00884838059115
    • 00884838054189
    • 00884838054196
    • 00884838054226
    • 00884838054219
    • 00884838054271
    • 23040202

Recall details

Company began the recall
Sold in

Worldwide distribution - US Nationwide and the countries of Canada, Algeria, Argentina, Australia, Austria, Bangladesh, Belarus, Belgium, Brazil, Bulgaria, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Czech Republic, Denmark, Ecuador, Egypt, Finland, France, French Polynesia, Germany, Greece, Guinea, Honduras, Hong Kong, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Korea, Republic of, Kosovo, Lao, Lebanon, Lithuania, Malaysia, Maldives, Malta, Martinique, Mexico, Mongolia, Morocco, Myanmar, Nepal, Netherlands, New Caledonia, Norway, Oman, Pakistan, Palestine, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, R¿union, Romania, Russian Fed., Saudi Arabia, Singapore, Slovakia, South Africa, South Korea, Spain, Sri Lanka, Sudan, Sweden, Switzerland, Syria, Taiwan, Tanzania, Thailand, Trinidad & Tobago, Tunisia, T¿rkiye, Ukraine, United Kingdom, Uruguay, United Arab Emirates, Uzbekistan, Vietnam, Yemen.

Company
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Best, Netherlands
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99378
Recall number
Z-2928-2026
Quantity recalled
4,252 units

All recalls from PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)